IRIS
ZULLO, LODOVICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.358
AS - Asia 7
Totale 1.365
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 1.358
CN - Cina 4
SG - Singapore 3
Totale 1.365
Salva come PNG Salva come JPEG
Città #
Genoa 963
Vado Ligure 192
Rapallo 148
Genova 50
Bordighera 5
Singapore 2
Beijing 1
Xi'an 1
Totale 1.362
Salva come PNG Salva come JPEG
Nome #
Diagnosis of lung cancer following emergency admission: Examining care pathways, clinical outcomes, and advanced NSCLC treatment in an Italian cancer Center 117
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients 111
Radiomic detection of EGFR mutations in NSCLC 98
Prognostic value of immunotherapy-induced organ inflammation assessed on 18FDG PET in patients with metastatic non-small cell lung cancer 95
Current state of the art on the diagnosis and the role of target therapy for treatment of ROS1-rearranged non-small cell lung cancer: a narrative review 94
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario 94
Immunotherapy-chemotherapy combinations for non-small cell lung cancer: current trends and future perspectives 90
Exploring Response to Immunotherapy in Non-Small Cell Lung Cancer Using Delta-Radiomics 82
Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patients 80
Potential application of cryobiopsy for histo-molecular characterization of mediastinal lymph nodes in patients with thoracic malignancies: a case presentation series and implications for future developments 79
Metabolic parameters as biomarkers of response to immunotherapy and prognosis in non-small cell lung cancer (Nsclc): A real world experience 73
Novel emerging molecular targets in non-small cell lung cancer 71
The role of the immune metabolic prognostic index in patients with non-small cell lung cancer (Nsclc) in radiological progression during treatment with nivolumab 69
Immunotherapy in Adolescents and Young Adults: What Remains in Cancer Survivors? 68
Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab 54
Biological modifications of the immune response to COVID-19 vaccine in patients treated with rituximab and immune checkpoint inhibitors 49
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy 47
Molecular and Genetic Advances in Small Cell Lung Cancer Landscape: From Homogeneity to Diversity 43
Totale 1.414
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.692
article - articoli 6.692
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.384
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 3 0 0 0 0 2 0 0
2021/202259 2 0 0 4 0 0 0 3 25 4 10 11
2022/2023176 8 12 2 13 46 18 4 10 19 9 29 6
2023/2024178 6 22 9 19 12 20 27 10 9 13 4 27
2024/2025604 18 29 10 71 46 51 43 129 29 33 70 75
2025/2026392 129 92 81 90 0 0 0 0 0 0 0 0
Totale 1.414